Liothyronine sodium
- Product NDC
- 16714-166
- 11-digit product format
- 167140166
- Labeler code
- 16714
- Product ID
- 16714-166_215d81f8-589d-490f-a470-8c50fb7aad65
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northstar Rx LLC
- Application
- ANDA214803
- Marketing category
- ANDA
- Marketing start
- 2021-05-05
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 5 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liothyronine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIOTHYRONINE SODIUM | 5 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GCA9VV7D2N |
| Rxcui | 903456, 903697, 903703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16714-166-01 | Liothyronine sodium | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-166 | LIOTHYRONINE SODIUM TABLET [NORTHSTAR RX LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240814_c97dc9ec-af73-4836-aa0d-c27e66e792a9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-166-01 | 16714016601 | 100 TABLET in 1 BOTTLE (16714-166-01) | 100 tablet | 2021-05-05 | 0000-00-00 | No | No | Current |